Saatja: <
[email protected]>
Saadetud: 22.07.2020 18:03
Koopia: <
[email protected]>
Teema: WHO: C.L.27.2020 (Influenza during COVID-19)
Dear Member States of the World Health Organization,Please find attached,
in the six official languages, C.L.27.2020 regarding the threat of
influenza during the period of the COVID-19 response.Should you have
questions regarding C.L.27.2020 please send an email to
[email protected] regards,Department of Governing BodiesWorld Health
Organization
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.27.2020
The World Health Organization (WHO) presents its compliments to Member States and
has the honour to request support with addressing a matter of concern during the period of the
COVID-19 response.
Even with COVID-19 prevailing, the threat of influenza persists. Each year, seasonal
influenza can cause 3–5 million severe cases and up to 650 000 respiratory-related deaths
worldwide. The co-circulation of influenza and COVID-19 can worsen the impact on health
systems that are already overwhelmed. In addition, pandemic influenza could emerge any
moment anywhere, and thus constant vigilance is critical. Since 1952, the Global Influenza
Surveillance and Response System (GISRS), a public health network coordinated by WHO, has
supported global influenza prevention and control and has been leveraged for the COVID-19
response since it emerged.
WHO has recently observed a sharp decrease in influenza testing, reporting, and sharing of
viruses and data. Given the ongoing threat of influenza, all Member States are requested to
remain vigilant for influenza, including seasonal influenza virus variants or influenza viruses
with pandemic potential, and to maintain routine influenza vaccination programmes to protect
the vulnerable.
WHO extends particular thanks to those 122 Member States hosting a GISRS National
Influenza Centre (NIC) for their continuous support and encourages them to: (1) resume or
maintain routine influenza sentinel surveillance to monitor the trend and co-circulation of
influenza and other respiratory viruses, including COVID-19; (2) ensure the NIC has the
resources for the timely and optimal collection, testing, and sharing of influenza virus materials
with WHO collaborating centres; (3) resume or maintain timely and routine reporting of
influenza virological and epidemiological surveillance data to global or regional platforms; and
(4) as possible, screen routine sentinel surveillance specimens for COVID-19 as an essential
component of COVID-19 surveillance and report data to WHO through global or regional
influenza platforms.
WHO will be pleased to provide guidance and technical assistance as needed to assist
countries with preparing for the upcoming influenza seasons and leveraging GISRS for
COVID-19 surveillance and will be grateful for Member States’ commitment to implement these
requests.
Clarification or questions regarding this process can be addressed to Ms Ann Moen, Chief,
Influenza Preparedness and Response (
[email protected]).
The World Health Organization takes this opportunity to renew to Member States the
assurance of its highest consideration.
GENEVA, 22 July 2020